{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:30:01Z","timestamp":1789065001842,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020552","name":"Ministry of Higher Education, Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015518","name":"University of Nizwa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015518","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004787","name":"TRC","doi-asserted-by":"publisher","award":["BFP\/RGP\/CBS\/21\/006"],"award-info":[{"award-number":["BFP\/RGP\/CBS\/21\/006"]}],"id":[{"id":"10.13039\/501100004787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ejmech.2024.117174","type":"journal-article","created":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T02:02:25Z","timestamp":1734228145000},"page":"117174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Dihydrofolate reductase inhibitory potential of 1H-indole-based-meldrum linked 1H-1,2,3-triazoles as new anticancer derivatives: In-vitro and in-silico studies"],"prefix":"10.1016","volume":"283","author":[{"given":"Satya Kumar","family":"Avula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Rostami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sobia Ahsan","family":"Halim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajmal","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad U.","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Gibbons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Csuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Al-Harrasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.117174_bib1","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.bmcl.2011.12.011","article-title":"Design and synthesis of small molecular dual inhibitor of falcipain-2 and dihydrofolate reductase as antimalarial agent","volume":"22","author":"Huang","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.117174_bib2","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/med.21538","article-title":"Chemical space of Escherichia coli dihydrofolate reductase inhibitors: new approaches for discovering novel drugs for old bugs","volume":"39","author":"Srinivasan","year":"2019","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2024.117174_bib3","doi-asserted-by":"crossref","first-page":"12101","DOI":"10.1002\/slct.202102555","article-title":"An insight into synthetic strategies and recent developments of dihydrofolate reductase inhibitors","volume":"6","author":"Chawla","year":"2021","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2024.117174_bib4","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1080\/13543776.2022.2130752","article-title":"Dihydrofolate reductase inhibitors: patent landscape and phases of clinical development (2001\u20132021)","volume":"32","author":"Bhagat","year":"2022","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2024.117174_bib5","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature12327","article-title":"Structural basis for molecular recognition of folic acid by folate receptors","volume":"500","author":"Chen","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.117174_bib6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s40268-017-0206-8","article-title":"Adverse event profile of pyrimethamine-based therapy in toxoplasmosis: a systematic review","volume":"17","author":"Ben-Harari","year":"2017","journal-title":"Drugs R"},{"key":"10.1016\/j.ejmech.2024.117174_bib7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/j.1875-9114.1981.tb03548.x","article-title":"Trimethoprim: mechanisms of action, antimicrobial activity, bacterial resistance, pharmacokinetics, adverse reactions, and therapeutic indications","volume":"1","author":"Gleckman","year":"1981","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejmech.2024.117174_bib8","first-page":"430","article-title":"Potent antipneumocystis and antitoxoplasma activities of piritrexim","volume":"32","author":"Kovacs","year":"1988","journal-title":"a Lipid-Soluble Antifolate"},{"key":"10.1016\/j.ejmech.2024.117174_bib9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejmech.2015.01.055","article-title":"Synthesis and antitumor activity of a novel series of 6-substituted pyrrolo[2,3-d]pyrimidines as potential nonclassical antifolates targeting both thymidylate and purine nucleotide biosynthesis","volume":"93","author":"Liu","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117174_bib10","doi-asserted-by":"crossref","first-page":"9058","DOI":"10.1021\/acs.chemrev.8b00186","article-title":"Chemistry and properties of indolocarbazoles","volume":"118","author":"Janosik","year":"2018","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2024.117174_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27217586","article-title":"Indole-containing natural products 2019\u20132022: isolations, reappraisals, syntheses, and biological activities","volume":"27","author":"Umer","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.117174_bib12","doi-asserted-by":"crossref","first-page":"6895","DOI":"10.1021\/jo900986z","article-title":"Efficient and diverse synthesis of indole derivatives","volume":"74","author":"Liu","year":"2009","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2024.117174_bib13","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1021\/cr400676v","article-title":"Synthetic approaches to 3-(2-nitroalkyl) indoles and their use to access tryptamines and related bioactive compounds","volume":"114","author":"Lancianesi","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2024.117174_bib14","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1021\/cr900211p","article-title":"Marine indole alkaloids: potential new drug leads for the control of depression and anxiety","volume":"110","author":"Kochanowska-Karamyan","year":"2010","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2024.117174_bib15","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1021\/cr2003954","article-title":"Indoles in multicomponent processes (MCPs)","volume":"112","author":"Shiri","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2024.117174_bib16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/jhet.349","article-title":"Biological importance of the indole nucleus in recent years: a comprehensive review","volume":"47","author":"Sharma","year":"2010","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2024.117174_bib17","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.2174\/092986712803341449","article-title":"Send orders of reprints at reprints@ benthamscience.org 2-arylindoles: a privileged molecular scaffold with potent, broad-ranging pharma-cological activity","volume":"19","author":"Lal","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117174_bib18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.phrs.2007.08.002","article-title":"The potential insulin sensitizing and glucose lowering effects of a novel indole derivative in vitro and in vivo","volume":"56","author":"Li","year":"2007","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2024.117174_bib19","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1021\/jo8001276","article-title":"Structural diversity of organic chemistry. A scaffold analysis of the cas registry","volume":"73","author":"Lipkus","year":"2008","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2024.117174_bib20","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1016\/j.bmcl.2013.02.090","article-title":"Synthesis and antioxidant properties of substituted 2-phenyl-1H-indoles","volume":"23","author":"Karaaslan","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.117174_bib21","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1016\/j.bmc.2007.05.030","article-title":"Antimitotic activities of 2-phenylindole-3-carbaldehydes in human breast cancer cells","volume":"15","author":"Kaufmann","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117174_bib22","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1016\/j.bmcl.2007.06.017","article-title":"2-Aryl-N-acyl indole derivatives as liver X receptor (LXR) agonists","volume":"17","author":"Kher","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.117174_bib23","article-title":"Physostigmine for dementia due to Alzheimer's disease","volume":"2010","author":"Coelho Filho","year":"2001","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejmech.2024.117174_bib24","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev.med.60.042307.110802","article-title":"The expanded biology of serotonin","volume":"60","author":"Berger","year":"2009","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ejmech.2024.117174_bib25","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.3390\/molecules20022973","article-title":"Indole alkaloids from Catharanthus roseus: bioproduction and their effect on human health","volume":"20","author":"Almagro","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.117174_bib26","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.lfs.2005.09.007","article-title":"Indole alkaloid marine natural products: an established source of cancer drug leads with considerable promise for the control of parasitic, neurological and other diseases","volume":"78","author":"Gul","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2024.117174_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00096","article-title":"Indole alkaloids from plants as potential leads for antidepressant drugs: a mini review","volume":"8","author":"Hamid","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.117174_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2016.05.025","article-title":"Indoles \u2014 a promising scaffold for drug development","volume":"91","author":"V Sravanthi","year":"2016","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2024.117174_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112245","article-title":"Indole-based derivatives as potential antibacterial activity against methicillin-resistance Staphylococcus aureus (MRSA)","volume":"194","author":"Qin","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117174_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fchem.2019.00837","article-title":"Synthesis, antimicrobial activity, structure-activity relationship, and molecular docking studies of indole diketopiperazine alkaloids","volume":"7","author":"Jia","year":"2019","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2024.117174_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94904-z","article-title":"Synthesis, antioxidant and cytoprotective activity evaluation of C-3 substituted indole derivatives","volume":"11","author":"Jasiewicz","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.117174_bib32","doi-asserted-by":"crossref","first-page":"42036","DOI":"10.1021\/acsomega.2c03908","article-title":"Synthesis and anticancer evaluation of novel indole based arylsulfonylhydrazides against human breast cancer cells","volume":"7","author":"Gaur","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2024.117174_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112506","article-title":"The importance of indole and azaindole scaffold in the development of antitumor agents","volume":"203","author":"Han","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117174_bib34","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.intimp.2011.07.010","article-title":"Anti-inflammatory and antinociceptive activities of indole-imidazolidine derivatives","volume":"11","author":"Da Silva Guerra","year":"2011","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejmech.2024.117174_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113665","article-title":"Research progress of indole compounds with potential antidiabetic activity","volume":"223","author":"Zhu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117174_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112358","article-title":"Indole chalcones: design, synthesis, in vitro and in silico evaluation against Mycobacterium tuberculosis","volume":"198","author":"Ramesh","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117174_bib37","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1021\/ml3000462","article-title":"Novel cyclopropyl-indole derivatives as HIV non-nucleoside reverse transcriptase inhibitors","volume":"3","author":"Hassam","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.117174_bib38","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ejmech.2012.03.023","article-title":"Design and synthesis of new 4-pyrazolin-3-yl-1,2,3-triazoles and 1,2,3-triazol-4-yl-pyrazolin-1-ylthiazoles as potential antimicrobial agents","volume":"52","author":"Abdel-Wahab","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117174_bib39","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bioorg.2018.08.008","article-title":"Synthesis of 1H-1,2,3-triazole derivatives as new \u03b1-glucosidase inhibitors and their molecular docking studies","volume":"81","author":"Avula","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.117174_bib40","doi-asserted-by":"crossref","first-page":"12099","DOI":"10.1039\/C9NJ05685H","article-title":"Synthesis, characterization and in vitro anticancer activity of thiabendazole-derived 1,2,3-triazole derivatives","volume":"44","author":"El Bourakadi","year":"2020","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2024.117174_bib41","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s00044-021-02723-8","article-title":"New synthetic 1H-1,2,3-triazole derivatives of 3-O-acetyl-\u03b2-boswellic acid and 3-O-acetyl-11-keto-\u03b2-boswellic acid from Boswellia sacra inhibit carbonic anhydrase II in vitro","volume":"30","author":"Avula","year":"2021","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2024.117174_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103182","article-title":"Synthesis of novel (R)-4-fluorophenyl-1H-1,2,3-triazoles: a new class of \u03b1-glucosidase inhibitors","volume":"91","author":"Avula","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.117174_bib43","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1021\/ar900229z","article-title":"Meldrum's acids and 5-alkylidene meldrum's acids in catalytic Carbon\u2212Carbon bond-forming processes","volume":"43","author":"Dumas","year":"2010","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2024.117174_bib44","doi-asserted-by":"crossref","first-page":"9682","DOI":"10.1021\/ja052411r","article-title":"Catalytic, enantioselective, conjugate alkyne addition","volume":"127","author":"Kn\u00f6pfel","year":"2005","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.117174_bib45","doi-asserted-by":"crossref","first-page":"9899","DOI":"10.1021\/jo0618876","article-title":"Modular synthesis of tetrahydrofluorenones from 5-alkylidene meldrum's acids","volume":"71","author":"Fillion","year":"2006","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2024.117174_bib46","doi-asserted-by":"crossref","first-page":"10218","DOI":"10.1039\/C4CC04852K","article-title":"Organocatalysed multicomponent synthesis of pyrazolidinones: meldrum's acid approach","volume":"50","author":"Pair","year":"2014","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2024.117174_bib47","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.1021\/acs.orglett.5b02755","article-title":"Organocatalyzed multicomponent synthesis of isoxazolidin-5-ones","volume":"17","author":"Berini","year":"2015","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2024.117174_bib48","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.1039\/D1OB00395J","article-title":"Selected applications of Meldrum's acid \u2013 a tutorial","volume":"19","author":"Brosge","year":"2021","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2024.117174_bib49","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/cctc.201600247","article-title":"Meldrum's acid: a useful platform in asymmetric organocatalysis","volume":"8","author":"Pair","year":"2016","journal-title":"ChemCatChem"},{"key":"10.1016\/j.ejmech.2024.117174_bib50","doi-asserted-by":"crossref","first-page":"11342","DOI":"10.1039\/C7NJ02116J","article-title":"Palladacycles having normal and spiro chelate rings designed from bi- and tridentate ligands with an indole core: structure, synthesis and applications as catalysts","volume":"41","author":"Singh","year":"2017","journal-title":"New J. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424010560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424010560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T19:02:12Z","timestamp":1741287732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424010560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":50,"alternative-id":["S0223523424010560"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.117174","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dihydrofolate reductase inhibitory potential of 1H-indole-based-meldrum linked 1H-1,2,3-triazoles as new anticancer derivatives: In-vitro and in-silico studies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.117174","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117174"}}